Literature DB >> 24966483

Correlation of serum homocysteine levels with the severity of coronary artery disease.

Vijetha Shenoy1, Veena Mehendale2, Krishnananda Prabhu1, Ranjan Shetty3, Pragna Rao1.   

Abstract

Coronary artery disease (CAD) has become the most common cause of mortality in the entire world. Homocysteine is implicated as an early atherosclerotic promoter. We studied the relationship between levels of serum homocysteine with severity of coronary artery disease. Total of 70 subjects who scheduled for coronary angiogram consented to participate in this study. In all the patients Gensini scoring system was used to assess the severity of CAD. Venous samples were taken from the patients in fasting state before angiography. Homocysteine levels in patients were measured by enzyme linked immunosorbant method and were compared with respective Genseni scores of participants. Fasting serum homocysteine levels in CAD patients were significantly higher than patients without coronary artery disease (p < 0.001). Also Homocyseine levels correlated significantly with increasing severity of CAD (p < 0.001). Serum homocysteine levels correlated well with the severity of CAD.

Entities:  

Keywords:  Coronary artery disease (CAD); Gensini scoring system; Homocysteine

Year:  2013        PMID: 24966483      PMCID: PMC4062675          DOI: 10.1007/s12291-013-0373-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  25 in total

1.  Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study.

Authors:  Han-Tan Chai; Yung-Lung Chen; Sheng-Ying Chung; Tzu-Hsien Tsai; Cheng-Hsu Yang; Huang-Chung Chen; Pei-Hsun Sung; Cheuk-Kwan Sun; Li-Teh Chang; Chang-Qing Fan; Hon-Kan Yip
Journal:  Int Heart J       Date:  2011       Impact factor: 1.862

2.  MDGs: chronic diseases are not on the agenda.

Authors:  Valentin Fuster; Janet Voûte
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

Review 3.  Current and future directions of cardiovascular risk prediction.

Authors:  Sidney C Smith
Journal:  Am J Cardiol       Date:  2005-12-01       Impact factor: 2.778

Review 4.  The controversy over homocysteine and cardiovascular risk.

Authors:  P M Ueland; H Refsum; S A Beresford; S E Vollset
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

Review 5.  The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.

Authors:  Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

6.  Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans.

Authors:  P M Kanani; C A Sinkey; R L Browning; M Allaman; H R Knapp; W G Haynes
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

7.  Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function.

Authors:  William Bilsborough; Daniel J Green; Cyril D S Mamotte; Frank M van Bockxmeer; Gerard J O'Driscoll; Roger R Taylor
Journal:  Atherosclerosis       Date:  2003-07       Impact factor: 5.162

8.  Raised serum homocysteine levels in patients of coronary artery disease and the effect of vitamin B12 and folate on its concentration.

Authors:  R Abraham; M Joseph John; R Calton; J Dhanoa
Journal:  Indian J Clin Biochem       Date:  2006-03

9.  Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians.

Authors:  Wolfgang Herrmann; Heike Schorr; Rima Obeid; Jürgen Geisel
Journal:  Am J Clin Nutr       Date:  2003-07       Impact factor: 7.045

10.  An overview of the burden of non-communicable diseases in India.

Authors:  R Prakash Upadhyay
Journal:  Iran J Public Health       Date:  2012-03-31       Impact factor: 1.429

View more
  32 in total

1.  Association of MTHFR C677T (rs1801133) and A1298C (rs1801131) Polymorphisms with Serum Homocysteine, Folate and Vitamin B12 in Patients with Young Coronary Artery Disease.

Authors:  Rajni R Shivkar; Gayatri C Gawade; Meghana K Padwal; Arundhati G Diwan; Sumiran A Mahajan; Charushila Y Kadam
Journal:  Indian J Clin Biochem       Date:  2021-05-18

2.  Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.

Authors:  Ran Tian; Hong-Hong Liu; Si-Qin Feng; Yi-Fei Wang; Yi-Yang Wang; Yu-Xiong Chen; Hui Wang; Shu-Yang Zhang
Journal:  J Microbiol       Date:  2022-03-04       Impact factor: 2.902

3.  Adropin is associated with hyperhomocysteine and coronary atherosclerosis.

Authors:  Liang-Ping Zhao; Tao You; Siew-Pang Chan; Jian-Chang Chen; Wei-Ting Xu
Journal:  Exp Ther Med       Date:  2015-12-23       Impact factor: 2.447

4.  Circulating Thrombotic Risk Factors in Young Patients with Coronary Artery Disease Who Are on Statins and Anti-platelet Drugs.

Authors:  Reema George; Harikrishnan Sivadasanpillai; Narayani Jayakumari; Anugya Bhatt; Jissa V Thulaseedharan; Jaganmohan A Tharakan
Journal:  Indian J Clin Biochem       Date:  2015-12-22

5.  Clinical implication of homocysteine in premature acute coronary syndrome female patients: Its distribution and association with clinical characteristics and major adverse cardiovascular events risk.

Authors:  Yunfeng Zhao; Jun Zhang
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

6.  A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction.

Authors:  Chak Kwong Cheng; Jiang-Yun Luo; Chi Wai Lau; William Chi-Shing Cho; Chi Fai Ng; Ronald Ching Wan Ma; Xiao Yu Tian; Yu Huang
Journal:  Acta Pharmacol Sin       Date:  2021-01-25       Impact factor: 7.169

Review 7.  Role of homocysteine in the development of cardiovascular disease.

Authors:  Paul Ganguly; Sreyoshi Fatima Alam
Journal:  Nutr J       Date:  2015-01-10       Impact factor: 3.271

8.  Intermedin1-53 Protects Against Myocardial Fibrosis by Inhibiting Endoplasmic Reticulum Stress and Inflammation Induced by Homocysteine in Apolipoprotein E-Deficient Mice.

Authors:  Jin-Sheng Zhang; Yue-Long Hou; Wei-Wei Lu; Xian-Qiang Ni; Fan Lin; Yan-Rong Yu; Chao-Shu Tang; Yong-Fen Qi
Journal:  J Atheroscler Thromb       Date:  2016-04-06       Impact factor: 4.928

9.  Hyperhomocysteinemia Predicts the Severity of Coronary Artery Disease as Determined by the SYNTAX Score in Patients with Acute Coronary Syndrome.

Authors:  Muhammed Karadeniz; Taner Sarak; Mustafa Duran; Caglar Alp; Huseyin Kandemir; İbrahim Etem Celik; Vedat Simsek; Alparslan Kılıc
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

10.  Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors.

Authors:  Tianyu Li; Yang Chen; Jie Li; Xiaobo Yang; Haiying Zhang; Xue Qin; Yanling Hu; Zengnan Mo
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.